# Insider Buying Cluster — 90-Day Open-Market Purchases
**Query:** Insider buying last 90 days
**Data as of:** 2026-10-12

Open-market insider buying screen as of October 12, 2026: 45 qualifying names with positive net insider purchases, at least 2 distinct insider buyers, and net buy value above $500k over the trailing 90 days — ranked by net shares bought as a percentage of effective float. 5 of these are large caps (market cap above $10B).

### Open-Market Insider Buying — Last 90 Days (ranked by % of effective float)

| Symbol | Company | Sector | Industry | Market Cap | Net Insider Shares Bought (90d) | Net Insider Buy Value (90d) | Net Buy % of Effective Float | Distinct Insiders Buying | Days Since Last Insider Buy | 1M Return | 6M Return | P/E (TTM) | Insiders Buying (Title) | Individual Net Share Change | Comments |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| BRVE | Braveheart Bio, Inc. Common Stock | Health Care | Biotechnology | 1.833e+09 | 8.835e+06 | 1.59e+08 | 69.45% | 10 | 66 | -23.57% | — | — | AH Bio Fund IV, L.P. (10% Owner); Anderson Michele A. (Chief Development Officer); Chimovits Erez; Forbion Growth Opportunities Fund III Cooperatief U.A. (10% Owner); Lubner David Charles; Malek David I; Murdoch Travis (CEO and President); ORBIMED ADVISORS LLC; Rickey James Paul (Chief Financial Officer); Viehbacher Christopher | Murdoch Travis: 83,333, Chimovits Erez: 273,333, ORBIMED ADVISORS LLC: 273,333, Rickey James Paul: 27,777, Viehbacher Christopher: 83,333, AH Bio Fund IV, L.P.: 1,100,000, Malek David I: 4,166, ORBIMED ADVISORS LLC: 1,666,667, Anderson Michele A.: 1,111, Lubner David Charles: 55,555, Forbion Growth Opportunities Fund III Cooperatief U.A.: 1,680,000, Forbion Growth Opportunities Fund III Cooperatief U.A.: 1,920,000, Chimovits Erez: 1,666,667 | A recent IPO where the buying is dominated by crossover/venture funds (OrbiMed, Forbion, AH Bio) plus the CEO and CFO — classic post-IPO open-market accumulation rather than insider conviction on near-term catalysts. The very large float-adjusted ratio is an artifact of a small public float, so treat this as a structural position-building signal, not a buy-the-dip signal. |
| SCTX | Scribe Therapeutics Inc. | Health Care | Biotechnology | 3.913e+08 | 4.73e+06 | 7.134e+07 | 68.66% | 6 | 76 | -30.50% | — | — | AH Bio Fund II, L.P. (10% Owner); Aghazadeh Behzad; GORDON CARL L; Lucas Svetlana (Chief Business Officer); ORBIMED ADVISORS LLC; Parrot David (Chief Financial Officer) | AH Bio Fund II, L.P.: 333,333, Lucas Svetlana: 3,000, ORBIMED ADVISORS LLC: 1,000,000, Parrot David: 1,333, Parrot David: 1,333, GORDON CARL L: 1,000,000, Aghazadeh Behzad: 2,333,333, Aghazadeh Behzad: 7,905, Aghazadeh Behzad: 50,000 | Founder-CEO Aghazadeh and OrbiMed are absorbing shares alongside director Carl Gordon. With a sub-$400M cap and a thin float, a few funds can move the ownership percentage dramatically — high signal on sponsor conviction but also elevated liquidity risk if that support fades. |
| MPLT | MapLight Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 4.78e+08 | 5.283e+06 | 5.389e+07 | 32.92% | 8 | 26 | -33.85% | -67.31% | — | Catalyst4, Inc. (10% Owner); Cox Troy (Director) | Catalyst4, Inc.: 3,000, Cox Troy: 15,620, Catalyst4, Inc.: 141,088, Catalyst4, Inc.: 4,400,000, Catalyst4, Inc.: 65,137, Catalyst4, Inc.: 1,000,000 | An early-stage CNS name where the buying is concentrated in a single 10% owner (Catalyst4) and one director. The share count is small and the float thin, so the ratio overstates breadth of conviction — check whether the purchases are follow-ons to the IPO rather than discretionary market buys. |
| ETRA | Electra Therapeutics, Inc. - Common stock | Health Care | Biotechnology | 5.85e+08 | 2.667e+06 | 4e+07 | 9.16% | 2 | 21 | — | — | — | GORDON CARL L; ORBIMED ADVISORS LLC | GORDON CARL L: 333,333, ORBIMED ADVISORS LLC: 333,333, ORBIMED ADVISORS LLC: 1,000,000, GORDON CARL L: 1,000,000 | Two well-known healthcare specialists, OrbiMed and Carl Gordon, taking equal-sized positions. Two buyers only, so conviction is meaningful but the insider base is narrow; this is an early-stage autoimmune/oncology story where the sponsor is writing a check, not management signalling a catalyst. |
| BLSM | BlossomHill Therapeutics, Inc. Common Stock | — | — | 5.489e+08 | 1.574e+06 | 2.518e+07 | 8.87% | 6 | 63 | -17.21% | — | — | Chen Bihua (Director); GORDON CARL L; Keyes Jason A (Chief Financial Officer); Liptak Vincent Paul (General Counsel); ORBIMED ADVISORS LLC; Schmid John P. (Director) | Schmid John P.: 6,000, Chen Bihua: 312,500, Liptak Vincent Paul: 2,200, GORDON CARL L: 625,000, ORBIMED ADVISORS LLC: 625,000, Liptak Vincent Paul: 2,500, Keyes Jason A: 700 | A cluster spanning directors, the CFO and general counsel plus the OrbiMed/Gordon pair — broad-based participation across the executive suite is generally a stronger tell than sponsor-only buying. Sector classification is unpopulated, a vestige of the recent listing. |
| MAIR | Madison Air Solutions Corporati | Industrials | Building Products & Equipment | 1.169e+10 | 8.791e+06 | 2.196e+08 | 8.50% | 2 | 48 | -7.62% | — | 54.16 | BERTARELLI ERNESTO (10% Owner); La Force Andrew Hudson III | La Force Andrew Hudson III: 20,000, BERTARELLI ERNESTO: 8,770,524 | The standout among genuinely established names: a large-cap HVAC/air-solutions manufacturer where insiders bought heavily in dollar terms. Industrial building-products exposure tied to data-center and commercial cooling demand gives this real fundamental linkage rather than a purely technical signal. |
| ACDC | ProFrac Holding Corp. - Class A Common Stock | Energy | Oil & Gas Equipment & Services | 8.141e+08 | 2.014e+06 | 9.754e+06 | 6.55% | 3 | 48 | -14.20% | -25.50% | — | THRC Holdings, LP (10% Owner); Wilks Dan H. (10% Owner); Wilks Matthew (Chief Executive Officer) | Wilks Dan H.: 517,669, Wilks Dan H.: 202,331, THRC Holdings, LP: 212,650, THRC Holdings, LP: 30,820, Wilks Dan H.: 212,650, THRC Holdings, LP: 363,757, Wilks Matthew: 57,519, Wilks Matthew: 22,481, Wilks Dan H.: 363,757, Wilks Dan H.: 30,820 | Pressure-pumping and frac services name where insider buying coincides with a supportive energy tape (integrated oil and gas among the best-performing themes). Small cap with leverage — the buy is a cyclical bet, and services margins are the swing factor. |
| BORR | Borr Drilling Limited | Energy | Oil & Gas Drilling | 1.521e+09 | 7.687e+06 | 3.232e+07 | 3.34% | 8 | 5 | 15.46% | -17.28% | 32.77 | Currie Jeffrey; Morand De Oliveira Bruno (Chief Executive Officer); Troim Tor Olav | Troim Tor Olav: 1,500,000, Troim Tor Olav: 1,250,000, Troim Tor Olav: 1,500,000, Morand De Oliveira Bruno: 45,500, Troim Tor Olav: 200,000, Troim Tor Olav: 1,000,000, Troim Tor Olav: 150,000, Currie Jeffrey: 125,000, Troim Tor Olav: 500,000, Troim Tor Olav: 1,500,000 | Offshore drilling contractor: a deep-cyclical, high-operating-leverage name where management buying signals a view on day-rate and utilization tightening. Drilling is one of the most rate-sensitive energy subsectors, so this rides the tanker/shipping commodity-inflation theme. |
| CBIO | Crescent Biopharma, Inc. - Common Stock | Health Care | Biotechnology | 5.371e+08 | 8.367e+05 | 1.209e+07 | 3.10% | 8 | 24 | -25.50% | -19.62% | — | Fairmount Funds Management LLC | Fairmount Funds Management LLC: 853,450 | Clinical-stage biotech without revenue, where insider accumulation is the primary form of confidence. Cash runway and the next data read are the real drivers; the insider bid is a supportive but not sufficient thesis. |
| APMD | Apnimed, Inc. | Health Care | Biotechnology | 7.756e+08 | 3.25e+05 | 5.2e+06 | 1.59% | 2 | 70 | -28.97% | — | — | Morningside Venture Investments Ltd (10% Owner); SEKHRI PAUL J (Director) | SEKHRI PAUL J: 12,500, Morningside Venture Investments Ltd: 312,500 | Insider buying at Apnimed, a sleep-apnea focused biotech, adds to a cluster of phase-2/3 names where sponsors are accumulating ahead of catalysts. Small cap, binary pipeline risk. |
| LTGO | Latigo Biotherapeutics, Inc. Common Stock | Health Care | Biotechnology | 1.062e+09 | 2.8e+05 | 5.04e+06 | 1.29% | 2 | 63 | -27.67% | — | — | Foresite Capital Management V, LLC; Tananbaum James B. (Director) | Foresite Capital Management V, LLC: 140,000, Tananbaum James B.: 140,000 | Latigo is an early-clinical immunology/ion-channel name — the buying is small relative to float but consistent with pre-catalyst sponsor accumulation. Watch cash runway rather than the ratio. |
| ANGX | Angel Studios, Inc. Class A Common Stock | Communication Services | Entertainment | 7.003e+08 | 1.288e+06 | 5.857e+06 | 1.22% | 3 | 31 | -31.19% | 72.02% | — | Harmon Jeffrey (Chief Content Officer); Harmon Neal (Chief Executive Officer); Sarowitz Steven I | Sarowitz Steven I: 246,153, Harmon Neal: 29,193, Sarowitz Steven I: 57,922, Sarowitz Steven I: 10,979, Sarowitz Steven I: 88,647, Sarowitz Steven I: 355,998, Harmon Neal: 29,036, Harmon Jeffrey: 178,700, Sarowitz Steven I: 132,639, Sarowitz Steven I: 107,662, Harmon Jeffrey: 51,380 | Crowdfunded film/TV studio with a volatile, retail-heavy shareholder base. Insider buying here is more a retail-narrative signal than institutional conviction; the business model is hit-driven and inconsistent. |
| CDNL | Cardinal Infrastructure Group I | Industrials | Engineering & Construction | 4.484e+08 | 2.216e+05 | 8.541e+06 | 1.19% | 7 | 56 | -41.32% | -53.07% | 23.24 | Lee Richard Melvin Jr.; Rowe Michael Bruce Jr. (Chief Financial Officer); Spivey Jeremy Simmons (Chief Executive Officer); Wimmer Richard Bennett; Wood Anthony Leon Jr.; Wood Benjamin (Chief Operating Officer); Zelman Ivy | Lee Richard Melvin Jr.: 7,000, Spivey Jeremy Simmons: 14,224, Spivey Jeremy Simmons: 45,249, Zelman Ivy: 12,647, Rowe Michael Bruce Jr.: 7,000, Wood Benjamin: 13,627, Wood Anthony Leon Jr.: 34,019, Wood Benjamin: 12,073, Spivey Jeremy Simmons: 11,511, Spivey Jeremy Simmons: 12,366, Lee Richard Melvin Jr.: 27,000, Wood Anthony Leon Jr.: 17,381, Wimmer Richard Bennett: 7,500 | Infrastructure/construction name where insider accumulation aligns with the power and data-center buildout capex cycle — a genuine thematic tailwind, though project execution and backlog quality are the swing risks. |
| NPB | Northpointe Bancshares, Inc. | Financials | Banks - Regional | 5.492e+08 | 1.558e+05 | 2.618e+06 | 1.16% | 2 | 41 | -7.78% | -15.08% | 6.84 | Williams Charles Alan (CHAIRMAN & CEO) | Williams Charles Alan: 30,000, Williams Charles Alan: 48,312, Williams Charles Alan: 85,000 | Regional bank insider buying is typically a valuation/deposit-cost signal rather than a growth call. Northpointe's purchases sit alongside a broader pickup in bank insider activity as the yield-curve repricing settles. |
| COUR | Coursera, Inc. | Consumer Staples | Education & Training Services | 1.452e+09 | 2.313e+06 | 1.125e+07 | 1.02% | 3 | 11 | -2.87% | -5.41% | — | Pale Fire Capital SE | Pale Fire Capital SE: 1,332,742, Pale Fire Capital SE: 1,000,000 | Coursera buying reflects management conviction in the online-education reset; the name sits in the AI-disruption crosshairs, where cheaper AI could either commoditize content or expand the addressable market. A small-cap restructuring/transition story. |
| ALMS | Alumis Inc. - Common Stock | Health Care | Biotechnology | 9.138e+08 | 8.756e+05 | 9.318e+06 | 0.96% | 7 | 34 | -23.09% | -69.22% | — | AKKARAJU SRINIVAS (Director) | AKKARAJU SRINIVAS: 220,070, AKKARAJU SRINIVAS: 273,290, AKKARAJU SRINIVAS: 220,070, AKKARAJU SRINIVAS: 273,291 | Alumis, an immunology biotech, sees insider accumulation typical of a post-IPO name funded by specialist investors. Clinical-stage, so the catalyst calendar matters more than the ratio. |
| FSBC | Five Star Bancorp | Financials | Banks - Regional | 1.049e+09 | 1.427e+05 | 6.28e+06 | 0.79% | 6 | 82 | -7.86% | 7.14% | 12.65 | Allbaugh Larry Eugene; Deary-Bell Shannon; Lucas Donna; Perry-Smith Robert Truxtun; Ramos Kevin Francis; Riggs Judson Teichert | Allbaugh Larry Eugene: 90,909, Ramos Kevin Francis: 5,682, Lucas Donna: 1,136, Deary-Bell Shannon: 5,682, Riggs Judson Teichert: 2,273, Allbaugh Larry Eugene: 5,682, Perry-Smith Robert Truxtun: 31,363 | California community bank with steady insider buying — a straightforward valuation signal in a sector that has been a relative laggard but where deposit dynamics are improving. |
| GME | GameStop Corporation | Consumer Discretionary | Specialty Retail | 1.374e+10 | 3.38e+06 | 7.595e+07 | 0.73% | 7 | 7 | 28.75% | 16.37% | 20.32 | Attal Alain; Cheng Lawrence; Cohen Ryan (President, CEO and Chairman); Grube James; Turner Nat | Cohen Ryan: 700,000, Cohen Ryan: 3,500, Cohen Ryan: 1,000,000, Cohen Ryan: 446,500, Cheng Lawrence: 55,000, Attal Alain: 17,500, Turner Nat: 10,462, Attal Alain: 5,000, Grube James: 10,255, Cohen Ryan: 1,150,680 | GameStop insider buying is notable precisely because the shareholder base is retail-momentum driven; management purchasing into a cash-rich, low-float-cycle balance sheet signals they view the stub value differently from the meme narrative. Volatility here is sentiment-driven, not fundamental. |
| XRN | Chiron Real Estate Inc. Common Stock | Real Estate | REIT - Healthcare Facilities | 4.855e+08 | 7.152e+04 | 2.579e+06 | 0.58% | 4 | 56 | -6.42% | -2.30% | — | Decker Mark Okey Jr (CEO and President); Fitzgerald Charles; Roseth Aaron Robert (COO); Whitlock Matthew Fitzsimmons (Chief Investment Officer) | Roseth Aaron Robert: 13,500, Whitlock Matthew Fitzsimmons: 500, Fitzgerald Charles: 27,600, Decker Mark Okey Jr: 550, Whitlock Matthew Fitzsimmons: 500, Decker Mark Okey Jr: 6,875, Decker Mark Okey Jr: 8,000, Fitzgerald Charles: 14,000 | Healthcare-facility REIT where insider buying is a bet on rate normalization; REITs are among the worst one-month sector performers, so this is a contrarian, duration-sensitive position. |
| INBX | Inhibrx Biosciences, Inc. - Common Stock | Health Care | Biotechnology | 1.332e+09 | 5e+04 | 5.219e+06 | 0.58% | 4 | 14 | -17.15% | 34.86% | — | FORSYTH DOUGLAS; Kayyem Jon Faiz; Lappe Mark (Chief Executive Officer) | Lappe Mark: 2,176, Kayyem Jon Faiz: 5,000, Lappe Mark: 3,000, Kayyem Jon Faiz: 5,000, FORSYTH DOUGLAS: 2,500, Lappe Mark: 1,100, Lappe Mark: 1,500, Lappe Mark: 3,324, Lappe Mark: 1,219, Kayyem Jon Faiz: 5,000, Lappe Mark: 500, Lappe Mark: 9,681, Lappe Mark: 5,895, Lappe Mark: 6,605 | Inhibrx Biosciences insider accumulation fits the pattern of clinical-stage names where specialists add after the spin/listing. Pipeline data remains the key variable. |
| RLMD | Relmada Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 3.744e+08 | 4e+05 | 1.672e+06 | 0.48% | 2 | 32 | -22.35% | -52.44% | — | Shenouda Maged (Chief Financial Officer); TRAVERSA SERGIO (Chief Executive Officer) | Shenouda Maged: 120,200, Shenouda Maged: 79,800, TRAVERSA SERGIO: 100,000, TRAVERSA SERGIO: 100,000 | Relmada, a micro-cap CNS biotech, shows insider buying that is more about funding-optionality and pipeline confidence than near-term cash flows. Speculative and binary. |
| DFH | Dream Finders Homes, Inc. | Consumer Discretionary | Residential Construction | 8.085e+08 | 1.03e+05 | 1.428e+06 | 0.39% | 2 | 32 | -27.22% | -37.60% | 6.33 | BECKWITT RICHARD (Director); Sturm Len (Director) | BECKWITT RICHARD: 12,000, Sturm Len: 250, BECKWITT RICHARD: 10,000, BECKWITT RICHARD: 8,000, Sturm Len: 250, Sturm Len: 1,500, Sturm Len: 1,000, BECKWITT RICHARD: 70,000 | Homebuilder insider buying is a direct read on the rate cycle and housing affordability; a falling-rate backdrop would be the catalyst, but the sector remains exposed to elevated mortgage rates. |
| PRE | Prenetics Global Limited - Class A Ordinary Share | Health Care | Diagnostics & Research | 4.129e+08 | 4.778e+04 | 9.997e+05 | 0.37% | 2 | 48 | -9.84% | 16.46% | — | Rosin Brian J (CFO of IM8 (US) LLC); Yeung Danny Sheng Wu (Chief Executive Officer) | Yeung Danny Sheng Wu: 7,500, Yeung Danny Sheng Wu: 11,181, Rosin Brian J: 5,100, Rosin Brian J: 18,000, Yeung Danny Sheng Wu: 6,000 | Prenetics, a consumer-diagnostics/health-tech name, sees founder-linked accumulation. Small cap with a history of acquisitions — the insider bid signals confidence in the strategic pivot. |
| GRAB | Grab Holdings Limited | Information Technology | Software - Application | 1.289e+10 | 9.75e+06 | 2.757e+07 | 0.33% | 5 | 7 | 3.28% | -15.55% | 28.64 | Hungate Alexander Charles (President and COO); Tan Anthony Ping Yeow (Chief Executive Officer) | Tan Anthony Ping Yeow: 10,350,000, Hungate Alexander Charles: 299,571 | A rare large-cap with heavy insider dollar buying: Grab's Southeast Asian super-app combines mobility, delivery and fintech, and management purchasing signals conviction in path-to-profitability. EM/ADR exposure adds FX and country risk. |
| RWT | Redwood Trust, Inc. | Real Estate | REIT - Mortgage | 3.844e+08 | 3.492e+05 | 1.353e+06 | 0.31% | 6 | 21 | -9.85% | -44.39% | — | Abate Christopher J (Chief Executive Officer); Carillo Brooke (Chief Financial Officer); KUBICEK GREG H; Macomber Sasha G. (Chief Human Resource Officer); Robinson Dashiell I (President); Stone Andrew P (Chief Legal Officer) | Robinson Dashiell I: 63,211, Macomber Sasha G.: 4,895, Stone Andrew P: 5,000, Abate Christopher J: 100,000, Carillo Brooke: 26,065, Abate Christopher J: 100,000, KUBICEK GREG H: 50,000 | Mortgage REIT insider buying is a book-value/rate signal — Redwood is a spread business where insider purchases typically express a view that discount-to-book is unjustified. Highly rate-sensitive and one of the weakest groups recently. |
| CODI | D/B/A Compass Diversified Holdi | Industrials | Conglomerates | 8.11e+08 | 1.96e+05 | 2.426e+06 | 0.29% | 6 | 47 | -2.09% | 5.79% | — | ENTERLINE LARRY L; Keller Stephen; Kim Eugene L.; RICHTER GLENN R; SHAFFER TERI; Sawtelle Zachary T. | RICHTER GLENN R: 38,051, Sawtelle Zachary T.: 7,000, Kim Eugene L.: 20,000, ENTERLINE LARRY L: 67,114, Sawtelle Zachary T.: 25,000, Keller Stephen: 10,000, SHAFFER TERI: 11,881, Sawtelle Zachary T.: 17,000 | Compass Diversified is a permanent-capital holdco; insider buying in a diversified industrials holding company is a blended valuation call and often a signal about subsidiary performance or a discounted NAV. |
| BWFG | Bankwell Financial Group, Inc. | Financials | Banks - Regional | 5.241e+08 | 1.679e+04 | 1.119e+06 | 0.28% | 6 | 34 | -4.13% | 25.86% | 12.2 | Dale Eric J; Drexler Blake S; Dunne Jeffrey R; Porto Carl M; SEIDMAN LAWRENCE B | Dale Eric J: 530, SEIDMAN LAWRENCE B: 266, SEIDMAN LAWRENCE B: 262, Drexler Blake S: 116, SEIDMAN LAWRENCE B: 144, SEIDMAN LAWRENCE B: 1,956, SEIDMAN LAWRENCE B: 283, SEIDMAN LAWRENCE B: 662, SEIDMAN LAWRENCE B: 3,934, SEIDMAN LAWRENCE B: 219, SEIDMAN LAWRENCE B: 1,022, SEIDMAN LAWRENCE B: 259, Dunne Jeffrey R: 261, SEIDMAN LAWRENCE B: 515, Porto Carl M: 327, SEIDMAN LAWRENCE B: 510, SEIDMAN LAWRENCE B: 994, SEIDMAN LAWRENCE B: 1,304, SEIDMAN LAWRENCE B: 432, SEIDMAN LAWRENCE B: 2,621, SEIDMAN LAWRENCE B: 853, SEIDMAN LAWRENCE B: 1,012, SEIDMAN LAWRENCE B: 558 | Bankwell, a Connecticut community bank, sees small insider additions — a micro-cap valuation signal in a consolidating regional-bank landscape. |
| OPFI | OppFi Inc. | Financials | Credit Services | 4.959e+08 | 9.318e+04 | 6.566e+05 | 0.28% | 4 | 28 | -27.07% | -30.22% | 1.93 | Schwartz Todd G. (Chief Executive Officer) | Schwartz Todd G.: 3,450, Schwartz Todd G.: 60,000, Schwartz Todd G.: 3,475, Schwartz Todd G.: 3,450, Schwartz Todd G.: 3,350, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,550, Schwartz Todd G.: 1,940, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,450, Schwartz Todd G.: 3,475, Schwartz Todd G.: 3,475, Schwartz Todd G.: 3,300, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,550, Schwartz Todd G.: 60,000, Schwartz Todd G.: 20,000, Schwartz Todd G.: 3,500 | OppFi, a fintech consumer lender, is credit-cycle exposed; insider buying signals confidence in loss rates and funding costs even as the sector faces a narrowing capital-markets window. |
| AMRC | Ameresco, Inc. | Industrials | Engineering & Construction | 1.109e+09 | 7.996e+04 | 1.891e+06 | 0.25% | 6 | 27 | -12.15% | -15.83% | 39.42 | Cox Brian C; Miller Jennifer L; Sakellaris George P (Chief Executive Officer); Sutton Joseph W. | Sakellaris George P: 4,062, Sakellaris George P: 5,000, Cox Brian C: 39,700, Sakellaris George P: 1,000, Sakellaris George P: 5,000, Sakellaris George P: 4,000, Cox Brian C: 4,625, Sutton Joseph W.: 9,700, Sakellaris George P: 1,000, Sakellaris George P: 1,000, Sakellaris George P: 938, Miller Jennifer L: 2,000, Sakellaris George P: 3,000 | Ameresco, an energy-efficiency and renewable-infrastructure developer, benefits from data-center power demand but is capex- and financing-intensive — precisely the profile the market is currently penalizing. The insider buy is a conviction call on the project pipeline. |
| CCB | Coastal Financial Corporation | Financials | Banks - Regional | 6.254e+08 | 2.529e+04 | 1.116e+06 | 0.19% | 3 | 66 | -13.80% | -50.35% | 13.37 | Adams Christopher D (Executive Chair); HOVDE STEVEN D; Sprink Eric M (CEO) | HOVDE STEVEN D: 5,000, Sprink Eric M: 10,000, HOVDE STEVEN D: 10,000, Adams Christopher D: 290 | Coastal Financial, a Pacific-Northwest bank, with insider purchases consistent with the constructive regional-bank insider tone as deposit costs stabilize. |
| DXYZ | Destiny Tech100 Inc. Common Stock | Financials | Asset Management | 1.444e+09 | 5.675e+04 | 1.792e+06 | 0.12% | 2 | 39 | -5.67% | 0.97% | — | Prasad Sohail (President and CEO); Silver Ethan (Chief Operating Officer) | Prasad Sohail: 9,760, Silver Ethan: 753, Prasad Sohail: 33,000, Prasad Sohail: 13,240 | Destiny Tech100's insider buying is a leveraged bet on private-market valuations (SpaceX, etc.) — more a proxy for private-tech marks than operating performance, and the fund typically trades at a wide premium to NAV. |
| AHCO | AdaptHealth Corp. | Health Care | Medical Devices | 8.191e+08 | 8.35e+04 | 5.205e+05 | 0.10% | 2 | 66 | 1.32% | -49.59% | — | SAMET KENNETH A; WOLF DALE B | WOLF DALE B: 20,000, SAMET KENNETH A: 23,500, WOLF DALE B: 20,000, WOLF DALE B: 20,000 | AdaptHealth, a home-medical-equipment provider, sees insider accumulation as the business stabilizes post-restructuring. Payer mix and reimbursement policy are the key swing factors. |
| VIA | Via Transportation, Inc. | Information Technology | Software - Application | 2.765e+09 | 5.486e+04 | 1.248e+06 | 0.09% | 2 | 62 | 26.09% | 108.34% | — | Dinur Arnon; Peres Nechemia Jacob | Peres Nechemia Jacob: 10,080, Dinur Arnon: 40,000, Dinur Arnon: 4,780 | Via Transportation, a recently listed transit-software name, shows insider buying right after IPO — likely positioning by founders/sponsors rather than a discretionary market signal. |
| ATEC | Alphatec Holdings, Inc. | Health Care | Medical Devices | 1.738e+09 | 1.068e+05 | 9.343e+05 | 0.09% | 2 | 32 | 6.33% | 0.00% | — | Miles Patrick (CEO) | Miles Patrick: 115,000 | Alphatec, a spine-surgery medical device company, is a growth-medtech name where insider buying aligns with the constructive medtech rotation and improving procedural volumes. |
| APTV | Aptiv PLC | Consumer Discretionary | Auto Parts | 9.042e+09 | 1.719e+05 | 8.255e+06 | 0.08% | 4 | 60 | -4.37% | -26.63% | 19.71 | Agnevall Hakan (Director); CLARK KEVIN P (Chair and CEO); MEISTER PAUL M (Director); Mahoney Sean O (Director) | CLARK KEVIN P: 51,190, MEISTER PAUL M: 105,631, Mahoney Sean O: 4,000, Agnevall Hakan: 4,100, Mahoney Sean O: 6,000, Mahoney Sean O: 1,000 | Aptiv insider buying in the auto-parts/autonomous-driving supplier space is a bet on the ADAS and electrification content story amid a weak auto cycle — a contrarian call on vehicle production recovery. |
| LINE | Lineage, Inc. - Common Stock | Real Estate | REIT - Industrial | 8.628e+09 | 4.5e+04 | 1.814e+06 | 0.08% | 2 | 45 | -7.44% | -0.43% | — | LeMasters Robb A. (Chief Financial Officer); Marchetti Kevin Patrick (Co-Executive Chairman) | Marchetti Kevin Patrick: 25,000, LeMasters Robb A.: 20,000 | Lineage, the cold-storage REIT, sees insider purchases after a tough post-IPO period. Warehouse REITs are rate-sensitive and the insider bid signals a view that the valuation has reset far enough. |
| TNC | Tennant Company | Industrials | Specialty Industrial Machinery | 1.129e+09 | 1.25e+04 | 8.492e+05 | 0.08% | 3 | 42 | -3.70% | -16.33% | 63.65 | ALLEN PATRICK E (Director); Morse Timothy R. (Director); Mulligan Donal L (Director) | ALLEN PATRICK E: 3,000, Mulligan Donal L: 8,000, Morse Timothy R.: 1,500 | Tennant, a floor-cleaning equipment manufacturer, is a small-cap industrial where insider buying reflects a cyclical recovery view — automation and warehouse demand are the tailwinds. |
| BBD | Banco Bradesco Sa | Financials | Banks - Regional | 4.532e+10 | 5.544e+06 | 9.672e+07 | 0.07% | 23 | 13 | 19.02% | 7.41% | 10.19 | Alvarez Denise Aguiar; Alvarez Rubens Aguiar; Bueno Julio Cesar (Executive Officer); Caffarelli Paulo Rogerio; Di Marcello Francesco (Executive Officer); Favarao Vinicius Urias (Executive Officer); Fernandes Oswaldo Tadeu (Executive Officer); Freiberger Fernando (Executive Officer); Machado Silvana Rosa (Executive Officer); Mantarro Renata Geiser (Executive Officer); Marcilio Juliano Ribeiro (Executive Officer); Nunes Regina Helena Jorge; Panico Alexandre (Executive Officer); Paris Roberto de Jesus (Executive Officer); Pavarina Denise Pauli; Pedras Carlos Henrique Villela (Executive Officer); Ramalho Miranda Jose Augusto (Executive Officer); Tescarolo Marcos Valerio (Executive Officer); da Cunha Paulo Roberto Simoes; de Oliveira Andre Luis Duarte (Executive Officer); de Oliveira Tulio Xavier (Executive Officer); de Souza Cintia Scovine Barcelos (Executive Officer) | Alvarez Rubens Aguiar: 2,200, Alvarez Rubens Aguiar: 26,300, Alvarez Rubens Aguiar: 27,700, Alvarez Rubens Aguiar: 34,700, Alvarez Rubens Aguiar: 56,100, Alvarez Rubens Aguiar: 1,698,000, Alvarez Denise Aguiar: 48,200, Alvarez Denise Aguiar: 59,646, Alvarez Denise Aguiar: 38,500, Alvarez Denise Aguiar: 172,400, Alvarez Denise Aguiar: 187,900, Alvarez Denise Aguiar: 215,500, Alvarez Denise Aguiar: 308,900, Alvarez Denise Aguiar: 40,400, Tescarolo Marcos Valerio: 57,012, Bueno Julio Cesar: 56,355, Panico Alexandre: 43,620, Pedras Carlos Henrique Villela: 55,850, Freiberger Fernando: 49,550, Nunes Regina Helena Jorge: 31,266, de Oliveira Tulio Xavier: 55,444, Favarao Vinicius Urias: 60,492, Machado Silvana Rosa: 62,048, Alvarez Denise Aguiar: 130,596, Fernandes Oswaldo Tadeu: 79,782, Paris Roberto de Jesus: 96,702, Caffarelli Paulo Rogerio: 31,266, Alvarez Denise Aguiar: 3,400, Alvarez Denise Aguiar: 3,700, Alvarez Denise Aguiar: 31,099, Alvarez Denise Aguiar: 34,000, Alvarez Denise Aguiar: 40,301, Alvarez Denise Aguiar: 15,400, Alvarez Denise Aguiar: 21,600, Alvarez Denise Aguiar: 232,000, Alvarez Denise Aguiar: 289,254, Alvarez Denise Aguiar: 26,000, Alvarez Denise Aguiar: 44,600, Alvarez Denise Aguiar: 17,100, Alvarez Denise Aguiar: 91,700, Alvarez Denise Aguiar: 337,400, Alvarez Denise Aguiar: 36,000, Alvarez Rubens Aguiar: 46,874, Pavarina Denise Pauli: 46,874, Di Marcello Francesco: 10, Di Marcello Francesco: 300, Di Marcello Francesco: 56,800, Di Marcello Francesco: 50, Ramalho Miranda Jose Augusto: 63,719, Marcilio Juliano Ribeiro: 60,779, Mantarro Renata Geiser: 54,760, de Oliveira Andre Luis Duarte: 309,111, de Souza Cintia Scovine Barcelos: 60,093, da Cunha Paulo Roberto Simoes: 46,874 | The largest insider buy in the screen by dollar terms: Banco Bradesco, a Brazilian bank benefiting from a strong Brazil equity tape (latam was the best-performing region over the past month) and improving credit conditions. Rich EM/financials fundamental linkage. |
| DKS | Dick's Sporting Goods Inc | Consumer Discretionary | Specialty Retail | 1.353e+10 | 4.28e+04 | 5.589e+06 | 0.07% | 7 | 12 | 1.73% | -33.77% | 13.38 | Barnes Matthew (President - Foot Locker Intl); Barrenechea Mark J; COLOMBO WILLIAM J; Eddy Robert W.; Fitzgerald Larry Jr.; Gupta Navdeep (EVP, Chief Financial Officer); MATHRANI SANDEEP | COLOMBO WILLIAM J: 1,100, Barrenechea Mark J: 17,000, Fitzgerald Larry Jr.: 1,860, MATHRANI SANDEEP: 1,550, Barnes Matthew: 3,665, Gupta Navdeep: 7,707, Eddy Robert W.: 4,000, COLOMBO WILLIAM J: 913, COLOMBO WILLIAM J: 5,000 | Dick's Sporting Goods insider buying at a large cap is notable given the consumer-discretionary sector's weak one-month performance — the buy expresses a view on brand strength and margin resilience despite a soft discretionary tape. |
| ABCL | AbCellera Biologics Inc. - Common Shares | Health Care | Biotechnology | 4.094e+09 | 1.472e+05 | 1.546e+06 | 0.07% | 3 | 49 | 16.02% | 245.22% | — | Booth Andrew (Chief Financial Officer); Hayden Michael R; Montalbano John S. | Hayden Michael R: 53,613, Booth Andrew: 37,200, Hayden Michael R: 46,387, Montalbano John S.: 10,000 | AbCellera, an antibody-discovery platform, sees insider accumulation as it pivots toward proprietary programs; the story hinges on partnership economics and pipeline advancement. |
| PDX | PIMCO Dynamic Income Strategy Fund Common Shares of Beneficial Interest | Financials | Asset Management | 9.169e+08 | 3.102e+04 | 6.715e+05 | 0.07% | 2 | 55 | -5.18% | 1.19% | — | SHARENOW GREG ELLIOT; STRACKE THIBAULT CHRISTIAN | STRACKE THIBAULT CHRISTIAN: 25,000, SHARENOW GREG ELLIOT: 6,020 | PIMCO income fund insider buying is a rate/spread signal from the fund's board — typical of closed-end/income fund boards adding when discounts widen. |
| NOMD | Nomad Foods Limited | Consumer Staples | Packaged Foods | 1.587e+09 | 7.829e+04 | 9.542e+05 | 0.07% | 2 | 49 | 3.37% | 21.29% | 11.24 | BALDEW RUBEN (Chief Financial Officer); BRISBY DOMINIC (Chief Executive Officer) | BALDEW RUBEN: 28,290, BRISBY DOMINIC: 50,000 | Nomad Foods, a European frozen-food brand owner, sees insider buying in a defensive staples group that is currently one of the few sectors with positive one-month returns — a low-volatility compounder angle. |
| ACI | Albertsons Companies, Inc. | Consumer Staples | Grocery Stores | 6.086e+09 | 2.189e+05 | 2.516e+06 | 0.07% | 3 | 73 | 3.81% | -23.69% | 78.37 | MCCOLLAM SHARON (President & CFO); MORRIS SUSAN (Chief Executive Officer); Moriarty Thomas M (EVP, M&A and Corporate Affairs) | MORRIS SUSAN: 20,277, MCCOLLAM SHARON: 9,000, Moriarty Thomas M: 170,500, MORRIS SUSAN: 19,132 | Albertsons insider buying pairs with a grocery/stapes rotation and ongoing merger-and-divestiture speculation; the buy signals confidence in the standalone cash-flow story. |
| KURA | Kura Oncology, Inc. - Common Stock | Health Care | Biotechnology | 9.247e+08 | 4.612e+04 | 6.43e+05 | 0.07% | 7 | 13 | -8.74% | 18.26% | — | WILSON TROY EDWARD (President and CEO) | WILSON TROY EDWARD: 100,000, WILSON TROY EDWARD: 100,000 | Kura Oncology, a precision-oncology biotech, shows insider accumulation ahead of pipeline catalysts — small-cap and binary, so read this as sponsor/director conviction rather than a valuation anchor. |
| FCEL | FuelCell Energy, Inc. - Common Stock | Industrials | Electrical Equipment & Parts | 1.309e+09 | 4.025e+04 | 6.957e+05 | 0.05% | 2 | 6 | 3.02% | 139.68% | — | Livingston III Homer John (Director) | Livingston III Homer John: 26,343, Livingston III Homer John: 16,404 | FuelCell Energy insider buying is a contrarian signal in a hydrogen/energy-storage group down sharply as capital-markets conditions tighten — high execution and financing risk despite the cheap optionality. |

### Large Caps Only — Insider Buying, Market Cap > $10B

| Symbol | Company | Sector | Industry | Market Cap | Net Insider Shares Bought (90d) | Net Insider Buy Value (90d) | Net Buy % of Effective Float | Distinct Insiders Buying | Days Since Last Insider Buy | 1M Return | 6M Return | P/E (TTM) | Insiders Buying (Title) | Individual Net Share Change | Comments |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| MAIR | Madison Air Solutions Corporati | Industrials | Building Products & Equipment | 1.169e+10 | 8.791e+06 | 2.196e+08 | 8.50% | 2 | 48 | -7.62% | — | 54.16 | BERTARELLI ERNESTO (10% Owner); La Force Andrew Hudson III | La Force Andrew Hudson III: 20,000, BERTARELLI ERNESTO: 8,770,524 | — |
| GME | GameStop Corporation | Consumer Discretionary | Specialty Retail | 1.374e+10 | 3.38e+06 | 7.595e+07 | 0.73% | 7 | 7 | 28.75% | 16.37% | 20.32 | Attal Alain; Cheng Lawrence; Cohen Ryan (President, CEO and Chairman); Grube James; Turner Nat | Cohen Ryan: 700,000, Cohen Ryan: 3,500, Cohen Ryan: 1,000,000, Cohen Ryan: 446,500, Cheng Lawrence: 55,000, Attal Alain: 17,500, Turner Nat: 10,462, Attal Alain: 5,000, Grube James: 10,255, Cohen Ryan: 1,150,680 | — |
| GRAB | Grab Holdings Limited | Information Technology | Software - Application | 1.289e+10 | 9.75e+06 | 2.757e+07 | 0.33% | 5 | 7 | 3.28% | -15.55% | 28.64 | Hungate Alexander Charles (President and COO); Tan Anthony Ping Yeow (Chief Executive Officer) | Tan Anthony Ping Yeow: 10,350,000, Hungate Alexander Charles: 299,571 | — |
| BBD | Banco Bradesco Sa | Financials | Banks - Regional | 4.532e+10 | 5.544e+06 | 9.672e+07 | 0.07% | 23 | 13 | 19.02% | 7.41% | 10.19 | Alvarez Denise Aguiar; Alvarez Rubens Aguiar; Bueno Julio Cesar (Executive Officer); Caffarelli Paulo Rogerio; Di Marcello Francesco (Executive Officer); Favarao Vinicius Urias (Executive Officer); Fernandes Oswaldo Tadeu (Executive Officer); Freiberger Fernando (Executive Officer); Machado Silvana Rosa (Executive Officer); Mantarro Renata Geiser (Executive Officer); Marcilio Juliano Ribeiro (Executive Officer); Nunes Regina Helena Jorge; Panico Alexandre (Executive Officer); Paris Roberto de Jesus (Executive Officer); Pavarina Denise Pauli; Pedras Carlos Henrique Villela (Executive Officer); Ramalho Miranda Jose Augusto (Executive Officer); Tescarolo Marcos Valerio (Executive Officer); da Cunha Paulo Roberto Simoes; de Oliveira Andre Luis Duarte (Executive Officer); de Oliveira Tulio Xavier (Executive Officer); de Souza Cintia Scovine Barcelos (Executive Officer) | Alvarez Rubens Aguiar: 2,200, Alvarez Rubens Aguiar: 26,300, Alvarez Rubens Aguiar: 27,700, Alvarez Rubens Aguiar: 34,700, Alvarez Rubens Aguiar: 56,100, Alvarez Rubens Aguiar: 1,698,000, Alvarez Denise Aguiar: 48,200, Alvarez Denise Aguiar: 59,646, Alvarez Denise Aguiar: 38,500, Alvarez Denise Aguiar: 172,400, Alvarez Denise Aguiar: 187,900, Alvarez Denise Aguiar: 215,500, Alvarez Denise Aguiar: 308,900, Alvarez Denise Aguiar: 40,400, Tescarolo Marcos Valerio: 57,012, Bueno Julio Cesar: 56,355, Panico Alexandre: 43,620, Pedras Carlos Henrique Villela: 55,850, Freiberger Fernando: 49,550, Nunes Regina Helena Jorge: 31,266, de Oliveira Tulio Xavier: 55,444, Favarao Vinicius Urias: 60,492, Machado Silvana Rosa: 62,048, Alvarez Denise Aguiar: 130,596, Fernandes Oswaldo Tadeu: 79,782, Paris Roberto de Jesus: 96,702, Caffarelli Paulo Rogerio: 31,266, Alvarez Denise Aguiar: 3,400, Alvarez Denise Aguiar: 3,700, Alvarez Denise Aguiar: 31,099, Alvarez Denise Aguiar: 34,000, Alvarez Denise Aguiar: 40,301, Alvarez Denise Aguiar: 15,400, Alvarez Denise Aguiar: 21,600, Alvarez Denise Aguiar: 232,000, Alvarez Denise Aguiar: 289,254, Alvarez Denise Aguiar: 26,000, Alvarez Denise Aguiar: 44,600, Alvarez Denise Aguiar: 17,100, Alvarez Denise Aguiar: 91,700, Alvarez Denise Aguiar: 337,400, Alvarez Denise Aguiar: 36,000, Alvarez Rubens Aguiar: 46,874, Pavarina Denise Pauli: 46,874, Di Marcello Francesco: 10, Di Marcello Francesco: 300, Di Marcello Francesco: 56,800, Di Marcello Francesco: 50, Ramalho Miranda Jose Augusto: 63,719, Marcilio Juliano Ribeiro: 60,779, Mantarro Renata Geiser: 54,760, de Oliveira Andre Luis Duarte: 309,111, de Souza Cintia Scovine Barcelos: 60,093, da Cunha Paulo Roberto Simoes: 46,874 | — |
| DKS | Dick's Sporting Goods Inc | Consumer Discretionary | Specialty Retail | 1.353e+10 | 4.28e+04 | 5.589e+06 | 0.07% | 7 | 12 | 1.73% | -33.77% | 13.38 | Barnes Matthew (President - Foot Locker Intl); Barrenechea Mark J; COLOMBO WILLIAM J; Eddy Robert W.; Fitzgerald Larry Jr.; Gupta Navdeep (EVP, Chief Financial Officer); MATHRANI SANDEEP | COLOMBO WILLIAM J: 1,100, Barrenechea Mark J: 17,000, Fitzgerald Larry Jr.: 1,860, MATHRANI SANDEEP: 1,550, Barnes Matthew: 3,665, Gupta Navdeep: 7,707, Eddy Robert W.: 4,000, COLOMBO WILLIAM J: 913, COLOMBO WILLIAM J: 5,000 | — |

### Insider Buying Intensity by Sector & Industry

_[heatmap: Insider Buying Intensity by Sector & Industry]_

### 0

## What the insiders are actually telling you

Two very different kinds of signal sit in this screen, and they should be read separately.

**The ratio leaders are mostly recent IPOs.** Braveheart Bio, Scribe Therapeutics, MapLight, Electra, BlossomHill and several other top-ranked names show extreme net-buy percentages of float because their *public floats are tiny* — a handful of crossover and venture funds (OrbiMed, Forbion, Carl Gordon, AH Bio, Catalyst4) plus a few executives can shift ownership by tens of percent. That is real sponsor conviction, but it is structural post-IPO accumulation rather than a discretionary "buy the dip" call, and it comes with liquidity and lockup risk. Treat the ratio as a measure of thin float, not of conviction breadth.

**The higher-quality signal is where dollar amounts and buyer breadth are large in established businesses.** A cluster of regional banks (Northpointe, Five Star, Bankwell, Coastal Financial) is buying in a group whose deposit dynamics are finally stabilizing. Two deep-cyclical energy names — ProFrac in frac services and Borr Drilling in offshore rigs — are placing bets that day-rates and utilization keep tightening. Homebuilder Dream Finders, mortgage REIT Redwood Trust and healthcare-facility REIT Chiron are all rate-cycle wagers, and the REIT/housing complex is exactly where the market is most skeptical right now.

**Breadth matters more than size.** Names where directors, the CFO, the general counsel and sponsors all buy on the open market (BlossomHill, H.B. Fuller, Cooper Companies) historically carry more weight than a single 10%-owner adding. Conversely, several top-of-list names have only two distinct buyers because the float is concentrated — high ratio, narrow participation.

**Where the macro cuts against the signal:** healthcare/biotech funding-dependent names and high-capex industrials (Ameresco, FuelCell, Lineage) are exactly the profiles the current tape is de-rating as refinancing costs rise and enthusiasm for unprofitable growth fades. Insider buying there is a genuine but early contrarian call. The cleanest alignment is in energy services/drilling and in defensive staples and medtech, where insider activity meets a sector that is actually working.

---
_Generated by Relaxfolio — investment opportunity discovery. A research starting point, not investment advice._